“This was a deal,” says Kucinich. “They promised PhRMA”—the Pharmaceutical Research and Manufacturers of America—“they wouldn’t back reimportation and bulk negotiating for Medicare purchases of drugs. And this is what they gave the health insurance industry. They backed off the antitrust exemption.”
